HomeALRN • NASDAQ
add
Aileron Therapeutics Inc
Previous close
$4.75
Day range
$4.51 - $4.99
Year range
$1.01 - $7.42
Market cap
81.48M USD
Avg Volume
102.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
AMZN
1.30%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.30M | 55.26% |
Net income | -7.34M | -61.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.25M | -55.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.31M | -18.50% |
Total assets | 106.01M | 381.70% |
Total liabilities | 7.71M | 127.87% |
Total equity | 98.30M | — |
Shares outstanding | 4.89M | — |
Price to book | 3.37 | — |
Return on assets | -30.72% | — |
Return on capital | -33.33% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.34M | -61.40% |
Cash from operations | -10.39M | -135.68% |
Cash from investing | -96.00K | -102.02% |
Cash from financing | 15.79M | — |
Net change in cash | 5.24M | 1,377.18% |
Free cash flow | -3.15M | -19.08% |
About
Founded
2001
Headquarters
Website
Employees
6